Novacyt half year 2017 results ENG Paris, France and Cambridge, UK – 16th August 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces unaudited reviewed financial results for the six months ended 30 June 2017.
Visit PageNews and Events
NOVACYT REVENUES HALF YEAR 2017 Consolidated sales growth +53% CER Group continues positive outlook for 2017
Novacyt revenues half year 2017 ENGLISH Paris, France and Cambridge, UK – 20th July 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces its unaudited revenues for the six months ended 30 June 2017 (the “Period”).
Visit PageNOVACYT SUCCESSFULLY COMPLETES €3.0M FUNDRAISING
Novacyt Financing PR ENG (20-06-17) FINAL Momentum towards profitability continues through H1 2017 Investing to support increased sales demand across business
Visit Page